» Articles » PMID: 6134671

Comparison of Beta-adrenoceptor Blockers and Calcium Antagonists in Hypertension

Overview
Journal Hypertension
Date 1983 Jul 1
PMID 6134671
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The calcium antagonist drug, verapamil, was compared in double-blind, double-dummy, crossover studies with two beta-adrenoceptor blocking drugs, pindolol and labetalol. All were equally effective as antihypertensive drugs in patients with mild-to-moderate hypertension. Verapamil caused a fall in blood pressure by reducing total peripheral resistance, as judged by echocardiographic studies, and had no adverse effects on airways resistance in patients with obstructive airways disease. The favorable hemodynamic effects and absence of serious side effects suggest that verapamil may be an important advance in the treatment of hypertension.

Citing Articles

Effects of calcium antagonists on adrenaline-induced hypokalaemia.

Mimran A, Ribstein J, Sissmann J Drugs. 1993; 46 Suppl 2:103-7.

PMID: 7512462 DOI: 10.2165/00003495-199300462-00018.


Drug treatment of hypertension.

Prichard B Drugs. 1988; 35 Suppl 6:40-52.

PMID: 3042360 DOI: 10.2165/00003495-198800356-00006.


Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.

MBuyamba-Kabangu J, Lepira B, Fagard R, Lijnen P, Ditu M, Tshiani K Eur J Clin Pharmacol. 1986; 29(5):523-7.

PMID: 2869952 DOI: 10.1007/BF00635887.


Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

McTavish D, Sorkin E Drugs. 1989; 38(1):19-76.

PMID: 2670511 DOI: 10.2165/00003495-198938010-00003.


Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Goa K, Benfield P, Sorkin E Drugs. 1989; 37(5):583-627.

PMID: 2663413 DOI: 10.2165/00003495-198937050-00002.